SN7
SHORT NOTE
5M
Classify drug interactions. Describe the pharmacokinetic and pharmacodynamic interactions with examples.
Definition and Classification
A drug interaction occurs when the effect of one drug is altered by the prior or concurrent administration of another drug, food, or chemical.
| Type | Basis | Examples |
|---|---|---|
| Pharmaceutical | Physical or chemical incompatibility outside the body, in the syringe or infusion | Penicillin inactivated by mixing with an aminoglycoside; diazepam precipitates in infusion fluids; calcium with ceftriaxone |
| Pharmacokinetic | One drug alters the absorption, distribution, metabolism or excretion of another — the plasma concentration changes | See below |
| Pharmacodynamic | The drugs act on the same receptor, system or physiological process; the plasma concentration is unchanged | See below |
Pharmacokinetic Interactions
| Stage | Mechanism | Examples |
|---|---|---|
| Absorption | Chelation, adsorption, altered pH, altered motility, altered gut flora | Calcium, iron and antacids chelate tetracyclines and fluoroquinolones; cholestyramine binds digoxin and warfarin; metoclopramide speeds gastric emptying |
| Distribution | Displacement from plasma protein binding | Aspirin, sulphonamides and phenylbutazone displace warfarin; sulphonamides displace bilirubin in neonates, risking kernicterus |
| Metabolism | Enzyme induction or inhibition | Rifampicin (inducer) causes oral contraceptive failure; erythromycin (inhibitor) with a statin causes rhabdomyolysis |
| Excretion | Competition for tubular secretion; altered urine pH; altered renal blood flow | Probenecid blocks penicillin and methotrexate secretion; NSAIDs and diuretics raise lithium levels; bicarbonate increases aspirin excretion |
Pharmacodynamic Interactions
| Type | Meaning | Examples |
|---|---|---|
| Additive (summation) | 1 + 1 = 2 | Aspirin with paracetamol |
| Synergism (potentiation) | 1 + 1 = greater than 2 | Trimethoprim with sulphamethoxazole (sequential blockade); penicillin with an aminoglycoside; alcohol with benzodiazepines |
| Antagonism | One drug opposes the effect of another | Naloxone with morphine (competitive); vitamin K with warfarin (physiological); protamine with heparin (chemical); adrenaline with histamine (physiological) |
| Altered receptor sensitivity | Indirect modification | Diuretic-induced hypokalaemia increases digoxin toxicity — one of the commonest clinically significant interactions |
CLINICAL PEARL
The hypokalaemia interaction is worth stating carefully because it is pharmacoDYNAMIC, not pharmacokinetic. A thiazide does not alter the digoxin level at all. It lowers potassium, and since potassium and digoxin compete for the same site on the Na+/K+ ATPase, less potassium means more digoxin binding. The patient becomes toxic at a perfectly normal plasma level — which is why the level must always be read alongside the potassium.
Drugs Especially Prone to Harmful Interaction
- Those with a narrow therapeutic index — warfarin, digoxin, phenytoin, lithium, theophylline, aminoglycosides, ciclosporin, oral hypoglycaemics, cytotoxics
- Those with a steep dose–response curve
- Those requiring precise plasma levels — antiretrovirals, antiepileptics, immunosuppressants
- Patients at particular risk — the elderly, those on polypharmacy, and those with hepatic or renal impairment
Applied Aspects
- Take a complete drug history including over-the-counter, herbal and traditional medicines — patients rarely volunteer these, and in India ayurvedic and other traditional preparations are very widely used
- Not all interactions are harmful — many are used deliberately: carbidopa with levodopa, clavulanic acid with amoxicillin, probenecid with penicillin, naloxone in opioid overdose
- Separate the doses of interacting drugs where the interaction is one of absorption — tetracyclines and antacids by at least two hours
- Monitor when starting or stopping an interacting drug; the risk is as great on withdrawal as on introduction
- Prescribe as few drugs as possible — the number of potential interactions rises steeply with the number of drugs, and polypharmacy in the elderly is a major and avoidable cause of hospital admission
All questions in General Pharmacology: Pharmacokinetics
- Q1Classify the routes of drug administration. Describe their advantages and disadvantages. Add a note on the mechanisms of drug transport across membranes. ★
- Q2Define absorption and bioavailability. Describe the factors affecting them and add a note on first-pass metabolism. ★
- Q3Describe the distribution of drugs. Explain the volume of distribution, plasma protein binding and the barriers to distribution. ★
- Q4Define biotransformation. Describe phase I and phase II reactions and the factors modifying drug metabolism. ★
- Q5Describe the excretion of drugs. Explain clearance, half-life and the kinetics of elimination. Add a note on therapeutic drug monitoring. ★
- SN1Describe first-pass metabolism with its sites, consequences and clinical significance. ★
- SN2Define enzyme induction and inhibition. Compare them and describe their clinical consequences. ★
- SN3Define volume of distribution. Describe the factors affecting it and its clinical applications. ★
- SN4Differentiate zero-order from first-order kinetics with examples and clinical significance. ★
- SN5Define plasma half-life. Explain the plateau principle and the factors altering half-life. ★
- SN6Define prodrug. Give the reasons for using prodrugs with examples. ★
- SN7Classify drug interactions. Describe the pharmacokinetic and pharmacodynamic interactions with examples.